Gene · 56848
Papers2,132
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,132
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones. | Pharmaceuticals (Basel) | 2025 | 40006080 | PubTator, text mining | PubMed |
| Sphingosine kinase 2 in cancer: A review of its expression, function, and inhibitor development. | Int J Biol Macromol | 2025 | 39988169 | PubTator, text mining | PubMed |
| SphK2 promotes the progression of Helicobacter pylori-positive gastric cancer by regulating the Ras/MEK/ERK pathway. | Biochem Biophys Res Commun | 2025 | 39922056 | PubTator, text mining | PubMed |
| Serum metabolome profiling in patients with mild cognitive impairment reveals sex differences in lipid metabolism. | Neurobiol Dis | 2025 | 39617329 | PubTator, text mining | PubMed |
| S1P/S1PRs-TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis. | Br J Pharmacol | 2025 | 39581852 | PubTator, text mining | PubMed |
| Syntheses of differentially fluorinated triazole-based 1-deoxysphingosine analogues en route to SphK inhibitors. | Org Biomol Chem | 2025 | 39565065 | PubTator, text mining | PubMed |
| Sphingosine Kinase 2 Controls the Aggressive Phenotype of Oral Squamous Cell Carcinoma by Regulating miR-205 and miR-296 through p53. | Am J Pathol | 2025 | 39476954 | PubTator, text mining | PubMed |
| The placenta in fetal death: molecular evidence of dysregulation of inflammatory, proliferative, and fetal protective pathways. | Am J Obstet Gynecol | 2025 | 38908653 | PubTator, text mining | PubMed |
| A multi-omics approach identifies the key role of disorders of sphingolipid metabolism in Ang II-induced hypertensive cardiomyopathy myocardial remodeling. | Sci Rep | 2024 | 39638825 | PubTator, text mining | PubMed |
| Dual-band complex-amplitude metasurface empowered high security cryptography with ultra-massive encodable patterns. | Nanophotonics | 2024 | 39633737 | PubTator, text mining | PubMed |
| Survival prediction in patients with head and neck squamous cell carcinoma and novel mechanistic insights of S100A8/A9. | Discov Oncol | 2024 | 39546127 | PubTator, text mining | PubMed |
| Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential. | Cancer Cell Int | 2024 | 39462385 | PubTator, text mining | PubMed |
| A role for plasma membrane Ca2+ ATPases in regulation of cellular Ca2+ homeostasis by sphingosine kinase-1. | Pflugers Arch | 2024 | 39392480 | PubTator, text mining | PubMed |
| Targeting SNAI1-Mediated Colorectal Cancer Chemoresistance and Stemness by Sphingosine Kinase 2 Inhibition. | World J Oncol | 2024 | 39328328 | PubTator, text mining | PubMed |
| The sphingosine kinase 2 inhibitors ABC294640 and K145 elevate (dihydro)sphingosine 1-phosphate levels in various cells. | J Lipid Res | 2024 | 39182604 | PubTator, text mining | PubMed |
| 5-Fluorouracil resistance due to sphingosine kinase 2 overexpression in colorectal cancer is associated with myeloid-derived suppressor cell-mediated immunosuppressive effects. | BMC Cancer | 2024 | 39118083 | PubTator, text mining | PubMed |
| Sphingosine kinase 2 and p62 regulation are determinants of sexual dimorphism in hepatocellular carcinoma. | Mol Metab | 2024 | 38925249 | PubTator, text mining | PubMed |
| Discovery and biological evaluation of biaryl acetamide derivatives as selective and in vivo active sphingosine kinase-2 inhibitors. | Eur J Med Chem | 2024 | 38875809 | PubTator, text mining | PubMed |
| Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy. | Bioact Mater | 2024 | 38699243 | PubTator, text mining | PubMed |
| Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy. | Cell Commun Signal | 2024 | 38698424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56848/papers?page=4